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INTRODUCTION:  Glucose  storage  disease  type  IXa  (GSD  IXa)  is an  uncommon  condition  presenting  with
childhood  onset  hepatomegaly,  growth  retardation,  and  often,  fasting  ketosis  and  hypoglycemia.  Despite
its benign  course,  the  lack  of  dietary  counseling  may  favor  uncontrolled  weight  gain.  We investigated  the
efﬁcacy  of  bariatric  surgery  in  one  17  years  old  female  suffering  from  GSD  IXa and  morbid  obesity.
PRESENTATION  OF  CASE:  The  diagnosis  was  GSD  type  IXa  in  a patient  with  a  body  mass  index  (BMI)  of
45.5  kg/m2. Onset  of  hypoglycemia  was  reported  twice  each  month.  She  was  treated  her implanting  an
adjustable  gastric  banding  through  laparoscopy.  Three  years  after  surgery  the  patient  presents  a  BMI  of
30.1 kg/m2 and  an  excess  of  weight  loss  (EWL)  of 71.1%.  Only  once,  following  surgery,  she  had  to  deﬂate  her
band  to allow  a  faster  transit  of food  through  her stomach,  thus  reaching  a prompt  euglycemic  condition,
due  to an  incoming  hypoglycemic  crisis.
DISCUSSION:  Laparoscopic  adjustable  gastric  banding  (LAGB)  is one  of the  most  used approaches  toariatric surgery treat  morbid  obesity.  It  is  a  restrictive  procedure  unable  to affect  the  absorption  of  any  nutrient,  pre-
senting  a  very  low  intra  and  perioperative  complication  rate.  In  our  GSD  IXa  patient,  it offered  a  prompt
modiﬁcation  of food  intake  restriction  whenever  requested,  thus  avoiding  hypoglycemia.
CONCLUSION:  LAGB  is effective  in  determining  weight  loss  without  inducing  signiﬁcant  side effects  or
worsening  hypoglycemia,  in  this  morbid  obese  patient,  suffering  from  GSD  type  IXa.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
In last years, both clinical research and technical advance have
ed to an improvement of the efﬁcacy in the diagnosis and treat-
ent of several diseases of surgical interest.1,2 Obesity is a chronic
isease and bariatric surgical procedures allow the achievement
f substantial weight loss3 and major secondary health beneﬁts4–6
ven in the long term.7 Glycogen storage disease type IX (GSD type
X) results from a deﬁciency of phosphorylase kinase activity (PhK),
hich has a major regulatory role in the breakdown of glycogen.
wo variants of PhK deﬁciency are known, liver PhK deﬁciency or
SD type IXa and muscle PhK deﬁciency or GSD type IXc, which is
otably rarer.8 Patients suffering from GSD type IXa, present early
hildhood onset hepatomegaly and growth retardation, and often,
ut not always, fasting ketosis and hypoglycemia. Although obesity
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is uncommon in these patients, the suggested diet, high in complex
carbohydrates and protein, to prevent hypoglycemia, may  favor an
uncontrolled weight gain. In this light, under the periodical evalua-
tion of a metabolic nutritionist, routine monitoring of blood glucose
and blood ketones concentration as well as reduced food intake, are
prescribed.9
The case of a 17 years old female suffering from GSD type IXa
and presenting with a body mass index (BMI) of 45.5 kg/m2 treated
with LAGB, is here reported.
2. Case report
In October 2010 a 17 years old female was referred from
pediatrics department to our bariatric surgery unit. The diag-
nosis was GSD type IXa in a patient with a BMI  of 45.5 kg/m2
(weight 124 kg, height 165 cm). Her laboratory test showed a PhK
of 11.0 mol/min/gHb (normal hospital values 100–300) an amy-
loglucosidase level of 6 nmol/min/gHb (normal hospital values
0.6–3.5) a blood glucose level of 77 mg/dl (normal hospital val-
ues 60–110) an HbA1c of 6.3% (normal hospital values below 6.5%)
and a glycogen level of 17 mg/dl (normal hospital values 0–10).
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Table  1
Pre- and postoperative clinical and biochemical status.
Before surgery At 1 year of follow up At 3 years of follow up
Weight (kg) 124 100 82
BMI  (kg/m2) 45.5 36.7 30.1
EWL  % – 40.6 71.1
Total  bilirubin (mg/dl) 1.7a 1.6a 1.4a
Conjugated bilirubin (mg/dl) 0.2 0.1 0.2
AST  (U/l) 56a 48a 35
ALT  (U/l) 116a 75a 70a
Total cholesterol (mg/dl) 220a 210a 180
CPK  (U/l) 156a 144a 95
AP  (mmHg) 155/95a 130/90 120/80
pH  7.30 7.40 7.41
pO2% 82.0 91 95
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Higher than normal hospital range.
ee Table 1 for other values. A liver biopsy conﬁrmed the diagno-
is. Liver ultrasound showed hepatomegaly. A clinical presentation
f hypoglycemia was reported twice each month. It was  usually
reated with the assumption of sugar or chocolate. Due to the
enign course of the illness, dietary counseling had been aban-
oned in favor of an uncontrolled diet. As a consequence of frequent
onsumption of junk food, both her mother and her sister suffered
rom morbid obesity. Besides this clinical presentation, cardiopul-
onary, hormonal and psychological parameters were normal.
fter obtaining the authorization from our university ethic commit-
ee, following a thorough staff discussion, it was decided to implant
n this patient an adjustable gastric banding by laparoscopy. In
rder to get a signed informed consent to surgery, the patient and
er family were educated about the risk beneﬁt ratio of a bariatric
rocedure. Surgery was then performed as usual in about 45 min.
he “pars ﬂaccida technique” was used.10 As a technical variation,
he regulation port was  placed palpable into subcutaneous tissue
f left groin, and not ﬁxed to the deep muscular fascia. The postop-
rative period was uneventful and the patient was discharged on
econd postoperative day. During the ﬁrst control, at one week from
urgery, besides from all planned visits, she was taught to deﬂate
er band by aspiring water saline solution from the regulation port.
At three years from surgery the patient is now 82 kg (BMI
0.1 kg/m2) with an excess of weight loss (EWL) of 71.1%, in
ood conditions, with a glycemic status mostly unmodiﬁed and
n acceptable biochemical panel, see Table 1. She is now follow-
ng dietary counseling again although she admits the occasional
onsumption of sweets. Following hospital discharge, during the
ostoperative port regulation, the young patient and her family
ere taught about the management of the device. A staff nurse on
uty was however available 24 h a day. In only one circumstance,
ue to an incoming hypoglycemic crisis, she had to deﬂate her band
o allow a faster transit of food through the stomach, thus reaching
 prompt euglycemic condition.
. Discussion
The association between obesity and GSD type Ia has been
eported.11 This more aggressive GSD variant is characterized by
n unfavorable prognosis. GSD type IXa has on the other hand a
ore benign course, although hypoglycemia and hepatomegaly are
owever present. This is caused by the deﬁciency of PhK. It makes
he physiological amount of blood glucose from the breakdown
f glycogen, unavailable, whenever requested.8,9 Fasting hypo-
lycemia is routinely controlled by a monitored nutritional support,
hich includes frequent daytime feedings that are high in complex
arbohydrates and protein; conversely an uncontrolled or exces-
ive food intake may  turn into weight gain probably sustained by
nsulin resistance.1199 99
The management of morbid obese patients suffering from GSD
type IXa, in which dietary counseling and a change in life habits
have failed to induce weight loss, is complex. On one hand, bariatric
surgery may be indicated to achieve substantial weight loss and
improve or heal comorbidities; on the other, a surgical procedure
leading to restriction or malabsorption of food intake may  worsen
hypoglycemia if present.
According to this, while our patient fulﬁlled in general the oper-
ative criteria suggested by the Italian Society for bariatric and
Metabolic Surgery (SICOB) guidelines12 and by many other scien-
tiﬁc societies,13 on the other hand, our goal was to offer her a restric-
tive bariatric procedure presenting a very low perioperative com-
plication rate14 and which was, at the same time, unable to affect
the absorption of any nutrient. Furthermore, a prompt modiﬁcation
of food intake restriction whenever needed by the patient, thus
avoiding hypoglycemia, was requested. Laparoscopic adjustable
gastric banding (LAGB) met  these criteria. Other known restrictive
bariatric procedures, such as intragastric balloon or sleeve gastrec-
tomy are in fact not adjustable in response to the nutritional needs
of the patient, and may  determine a high risk to worsen hypo-
glycemia. Furthermore, LAGB efﬁcacy in the long term does not
only depend on the mechanical restriction to stomach ﬁlling, but
also on the neurological regulation of hunger and satiety possibly
mediated by mechanoreceptors present in the gastric wall.7,13
4. Conclusion
To our knowledge, this is the ﬁrst report of bariatric surgery in
a morbid obese patient suffering from GSD. Although type IXa is a
very mild expression of GSD and has a benign course, severe obesity
may  represent a serious complication; in the present case a morbid
obese patient suffering from GSD type IXa was effectively treated
with LAGB. This surgical procedure determined weight loss, with-
out inducing signiﬁcant side effects or worsening hypoglycemia.
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